Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors.
Saved in:
| Title: | Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. |
|---|---|
| Authors: | Milani, Mario1,2 (AUTHOR), Donalisio, Manuela1,3 (AUTHOR), Bonotto, Rafaela Milan4 (AUTHOR), Schneider, Edoardo5 (AUTHOR), Arduino, Irene3 (AUTHOR), Boni, Francesco1,2 (AUTHOR), Lembo, David3 (AUTHOR), Marcello, Alessandro1,4 (AUTHOR) marcello@icgeb.org, Mastrangelo, Eloise1,2 (AUTHOR) eloise.mastrangelo@cnr.it |
| Source: | Antiviral Research. May2021, Vol. 189, pN.PAG-N.PAG. 1p. |
| Database: | Environment Complete |
Be the first to leave a comment!
